Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates safety and efficacy of suprachoroidal triamcinolone acetonide delivered via microneedle for noninfectious uveitis, completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suprachoroidal Triamcinolone Acetonide via Microneedle (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Uveitis, Intermediate Uveitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-21